Navigation Links
Another Study Links Fluoride to Bone Cancer
Date:4/29/2009

a fluoride/bone cancer link plausible.

"If governments truly want to save money, stopping fluoridation is a no-brainer. It would save money, preserve health and teeth," says attorney Paul Beeber, President, New York State Coalition Opposed to Fluoridation.

In 2005, 11 Environmental Protection Agency (EPA) employee unions, representing over 7000 environmental and public health professionals called for a moratorium on fluoridation programs across the country and asked EPA management to recognize fluoride as posing a serious risk of causing cancer in people.(7)

In addition, over 2,430 professionals urge the U.S. Congress to stop fluoridation until Congressional hearings are conducted, citing scientific evidence that fluoridation, long promoted to fight tooth decay, is ineffective and has serious health risks. See statement:

http://www.fluoridealert.org/statement.august.2007.html

References: http://tinyurl.com/osteosarcom

    Contact:  Paul Beeber, JD   516-433-8882  nyscof@aol.com
   http://www.orgsites.com/ny/nyscof
   http://www.FluorideAction.Net


'/>"/>
SOURCE NYS Coalition Opposed to Fluoridation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Viatronix V3D-Colon Utilized in Another Landmark Study
2. Another LNA-based RNA Inhibitor Enters Clinical Trials
3. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
4. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
5. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
6. Allos Therapeutics Initiates Study of PDX in Patients with Cutaneous T-Cell Lymphoma
7. Multiple Myeloma Research Consortium (MMRC) Partners with Novartis to Advance Phase II Study of Deacetylase Inhibitor
8. Potential Safety Issue Identified in Ongoing Phase 2 Clinical Study of HCV-796
9. Study Suggests High-Dose Fish Oil May Significantly Improve Behavior in Children with ADHD
10. MicroDose Announces Positive Results From the QDose Inhaled Insulin Glucose Clamp Study
11. Video: Landmark Study in The Lancet: Patients Treated With Betaseron(R) After First MS Attack Experienced Significant Delay in MS Progression
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/6/2015)... Mar. 06, 2015 Research and Markets ... "European Patient Handling Equipment Market by Product, by ... Forecast to 2019" report to their offering. ... expected to grow at a double-digit CAGR of 11.4% ... Factors such as rising geriatric population, increasing incidences of ...
(Date:3/6/2015)... , March 6, 2015  Isis Pharmaceuticals, Inc. (NASDAQ: ... earned a $9 million milestone payment from Biogen Idec ... evaluating ISIS-SMN Rx in infants with spinal muscular ... study of ISIS-SMN Rx, is a randomized, double-blind, ... diagnosed with SMA.  The study will evaluate the efficacy ...
(Date:3/5/2015)...   MeridianRx earned highest possible score ... leading indicators during its recent URAC accreditation review ... very proud of earning this level of accreditation ... Operating Officer of MeridianRx. "It is a testament ... flexibility and innovation." URAC,s leading indicators ...
Breaking Medicine Technology:European Patient Handling Equipment (Wheelchair, Scooters, Bathroom Safety Supply, Mechanical, Ambulatory) Market 2015-2019 2European Patient Handling Equipment (Wheelchair, Scooters, Bathroom Safety Supply, Mechanical, Ambulatory) Market 2015-2019 3Isis Pharmaceuticals Earns $9M for Advancing ISIS-SMN Rx in Infants With Spinal Muscular Atrophy 2Isis Pharmaceuticals Earns $9M for Advancing ISIS-SMN Rx in Infants With Spinal Muscular Atrophy 3Isis Pharmaceuticals Earns $9M for Advancing ISIS-SMN Rx in Infants With Spinal Muscular Atrophy 4Isis Pharmaceuticals Earns $9M for Advancing ISIS-SMN Rx in Infants With Spinal Muscular Atrophy 5MeridianRx Earns Highest URAC Accreditation Status 2
... the vaccines division of sanofi-aventis Group (EURONEXT: SAN and NYSE: ... a Supplemental Biologics License Application (sBLA) with the U.S. Food ... Virus Vaccine).  The file has been accepted by the FDA ... of 2011. "Upon FDA licensure, this new ...
... Agreement With Enter Holdings -- TEL-AVIV, Israel, September 13, 2010 ... ... ... var first_result; // Results are keyed by longUrl, so we need to grab the first one. for ...
Cached Medicine Technology:FDA Accepts Sanofi Pasteur File Submission for Novel Influenza Vaccine Delivered by Intradermal Microinjection 2FDA Accepts Sanofi Pasteur File Submission for Novel Influenza Vaccine Delivered by Intradermal Microinjection 3FDA Accepts Sanofi Pasteur File Submission for Novel Influenza Vaccine Delivered by Intradermal Microinjection 4Elbit Imaging Announces Share Purchase Agreement With Enter Holdings 2Elbit Imaging Announces Share Purchase Agreement With Enter Holdings 3Elbit Imaging Announces Share Purchase Agreement With Enter Holdings 4Elbit Imaging Announces Share Purchase Agreement With Enter Holdings 5Elbit Imaging Announces Share Purchase Agreement With Enter Holdings 6Elbit Imaging Announces Share Purchase Agreement With Enter Holdings 7Elbit Imaging Announces Share Purchase Agreement With Enter Holdings 8Elbit Imaging Announces Share Purchase Agreement With Enter Holdings 9
(Date:3/6/2015)... Ticket Down is a reputable source for authentic ... Moda Center. After being away from the touring business ... signs of letting up on his “Garth Brooks World Tour.” ... Trisha Yearwood, to venues around the United States. The duo ... tour to the Moda Center in Portland, OR. The husband ...
(Date:3/6/2015)... As the Muscular Dystrophy Association continues to enhance its ... two new Scientific Program Officers, Amanda Haidet-Phillips, Ph.D and ... Pavlath, Ph.D, who joined MDA late last year as ... will lead MDA as it accelerates new front-line discovery ... of neuromuscular and motor neuron diseases. , ...
(Date:3/6/2015)... CA (PRWEB) March 06, 2015 US ... of three Maryland camps – two non-contact specialty camps ... be run by Perfect Performance Training, located at Bowie ... focus on developing position specific skills, speed and strength ... hosted at Salisbury University with Marvin Graves, former quarterback ...
(Date:3/6/2015)... 2015 Johnson & Johnson and Ethicon ... March 5, 2015 in Superior Court in the State ... a jury of 12 awarded Mrs. Perry $700,000 in ... with an Ethicon TVT Abbrevo plastic sling for stress ... women also awarded $5 million in punitive damages. , ...
(Date:3/6/2015)... March 06, 2015 Jvion, the ... release of a Clostridium Difficile (C Diff) predictive ... C Diff use case is the latest in ... hospital acquired infections, chronic conditions, and individual illnesses. ... C Diff solution flags at risk individuals to ...
Breaking Medicine News(10 mins):Health News:Garth Brooks Tickets in Portland, OR at the Moda Center: Ticket Down Slashes Garth Brooks Ticket Prices at the Moda Center in Portland 2Health News:Garth Brooks Tickets in Portland, OR at the Moda Center: Ticket Down Slashes Garth Brooks Ticket Prices at the Moda Center in Portland 3Health News:MDA Adds Muscle Disease and ALS Leaders to Research Team 2Health News:MDA Adds Muscle Disease and ALS Leaders to Research Team 3Health News:MDA Adds Muscle Disease and ALS Leaders to Research Team 4Health News:US Sports Camps to Host Three New Football Camps in Maryland 2Health News:Johnson & Johnson Hit with $5.7 Million Verdict in Pelvic Mesh Trial Announces Matthews & Associates Law Firm 2Health News:Johnson & Johnson Hit with $5.7 Million Verdict in Pelvic Mesh Trial Announces Matthews & Associates Law Firm 3Health News:Jvion Predicts Patients at Risk of C Difficile Infection to Reduce Risk and Save Lives 2
... UK, has provided new guidelines //for dealing with Post ... psychological therapy be given to victims of PTSD. ... tough. NICE had emphasized that apart from providing food, ... important to give them psychological care to help them ...
... created a new breed of mice that can reduce free ... ,The reactive oxygen of the free radicals are known ... health and even death. The new research may be the ... of ageing. ,The new mice created by the ...
... will help in medical practitioners to diagnose lupus disease in ... a condition that happens when the body’s tissues are affected ... may produce abnormal antibodies in their blood that may attack ... and virus. This may lead to disease of the lungs, ...
... depression may be two separate conditions that frequently co-exist. ... say that it is essential to treat depression and ... ,The researchers had studied 33 women and 20 men ... extensive tenderness to touch along with intense pain and ...
... the smoking habit of 6654 people for a period of ... do causes weight gain, but the overall health effect is ... measured for effect of giving up on smoking, gaining weight ... was 20 to 44yrs, and was measured once again for ...
... Medicine had been successful in developing an early test ... to finding of neutrophil gelatinase-associated lipocalin (NGAL) as an ... patient had a cardiopulmonary bypass surgery. ,Of the ... children had developed acute renal injury. The amount of ...
Cached Medicine News:
VascoScrew is a low profile unipolar pacing lead with a fixed screw for permanent pacing. Due to latest technologies, VascoScrew 6/60 M is compatible to all pacemaker-cavities with the size of IS-1 (...
VascoScrew is a low profile unipolar pacing lead with a fixed screw for permanent pacing. Due to latest technologies, VascoScrew 6/60 M is compatible to all pacemaker-cavities with the size of IS-1 (...
The VascoTip J 9/60 PU is a unipolar tined, J-preformed permanent pacing lead. Due to advanced technology, VascoTip J 9/60 PU M is compatible to all pacemaker-cavities with the size of IS-1 (3.2 mm),...
Steroid-eluting, screw-in pacing lead...
Medicine Products: